SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC
NT 10-Q, 1996-05-31
PLASTICS PRODUCTS, NEC
Previous: CAVALIER HOMES INC, S-8, 1996-05-31
Next: NATIONS FUND INC, 485APOS, 1996-05-31



                                   
                                                      



                   UNITED STATES
        SECURITIES AND EXCHANGE COMMISSION
              Washington, D.C. 20549

                    FORM 12b-25

            NOTIFICATION OF LATE FILING

(Check One):  [ ] Form 10-K   [ ] Form 20-F   [ ] Form 11-K   
              [x] Form 10-Q   [ ] Form N-SAR

         For Period Ended:  March 31, 1996
         [  ] Transition Report on Form 10-K
         [  ] Transition Report on Form 20-F
         [  ] Transition Report on Form 11-K
         [X ] Transition Report on Form 10-Q
         [  ] Transition Report on Form N-SAR
         For the Transition Period Ended:         

Read Instruction (on back page) Before Preparing Form.  Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has 
verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify 
the Item(s) to which the notification relates:

                                       

PART I - REGISTRANT INFORMATION

Specialized Health Products International, Inc.
- --------------------------------------------------
Full Name of Registrant

- ---------------------------------------------                      
Former Name if Applicable

655 East Medical Drive
- -----------------------------------
Address of Principal Executive Office (Street and Number)

Bountiful, Utah 84010
- ----------------------------
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or 
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the 
following should be completed.  (Check box if appropriate)

    (a)     The reasons described in reasonable detail in Part III 
            of this form could not be eliminated without unreasonable 
            effort or expense;

[x] (b)     The subject annual report, semi-annual report; transition report on 
            Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be 
            filed on or before the fifteenth calendar day following the 
            prescribed due date; or the subject quarterly report of transition 
            report on Form 10-Q, or portion thereof will be filed on or before 
            the fifth calendar day following the prescribed due date; and
    
    (c)     The accountant's statement or other exhibit required by Rule 
            12b-25(c) has been attached if applicable.
    
PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, 
N-SAR, or the transition report or portion thereof, could not be filed within 
the prescribed time period.  (Attach Extra Sheets If Needed)

The company's quarterly financial statements were not finalized until 
November 14, 1995.


PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in 
    regard to this notification:

    Eric L. Robinson                    (801) 521-7900      
        (Name)                     (Area Code)(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) 
    of the Securities Exchange Act of 1934 or Section 30 of the 
    Investment Company Act of 1940 during the preceding 12 months (or for 
    such shorter) period that the registrant was required to file such 
    reports) been filed?  If answer is no, identify report(s).
    [x] Yes   [ ] No
                                                                           

(3) Is it anticipated that any significant change in results of operations 
    from the corresponding period for the last fiscal year will be reflected 
    by the earnings statements to be included in the subject report or 
    portion thereof? [ ] Yes   [x] No

    If so, attach an explanation of the anticipated change, both narratively 
    and quantitatively, and, if appropriate, state the reasons why a reasonable 
    estimate of the results cannot be made.

                                                                    
              Specialized Health Products International, Inc.      
               (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned 
hereunto duly authorized.


Date      May 14, 1996            By:/s/David A. Robinson
                                  ------------------------
                                 David A. Robinson
                                 President, Chief Executive Officer, Director

INSTRUCTION:  The form may be signed by an executive officer of the registrant 
or by any other duly authorized representative.  The name and title of the 
person signing the form shall be typed or printed beneath the signature.  
If the statement is signed on behalf of the registrant by an authorized 
representative (other than an executive officer), evidence of the 
representative's authority to sign on behalf of the registrant shall be filed 
with the form.

                             ATTENTION

Intentional Misstatements or omissions of fact constitute Federal Criminal 
Violations (See 18 U.S.C. 1001).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission